PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9758210-6	1998	HPASMC treated with 200 U/ml of IL-1beta and 500 U/ml of TNF alpha produced more COX metabolites such as 6-keto-PGF1alpha, thromboxane B2, PGF2alpha and PGE2 than control cells.	6-Ketoprostaglandin F1 alpha	105-121	interleukin 1 beta	Homo sapiens	32-40	
10207838-4	1999	IL-1 beta significantly increased the levels of PGE2 and, to a lesser extent, those of 6-keto-PGF1 alpha (a stable metabolite of PGI2) in the culture media of HGF.	6-Ketoprostaglandin F1 alpha	87-104	interleukin 1 beta	Homo sapiens	0-9	
9836494-10	1998	SC-58125 inhibited lipopolysaccharide and interleukin-1beta stimulated 6-keto prostaglandin F1alpha but not prostaglandin E2 release.	6-Ketoprostaglandin F1 alpha	71-99	interleukin 1 beta	Homo sapiens	42-59	
1888884-2	1991	In addition, IL-1 beta dose-dependently stimulated the formation of prostaglandin E2 (PGE2) and 6-keto-PGF1 alpha in the calvarial bones.	6-Ketoprostaglandin F1 alpha	96-113	interleukin 1 beta	Homo sapiens	13-22	
9927229-10	1998	IL-1beta and LPS increased both PGE2 and 6-keto-PGF1alpha in a dose dependent fashion with enhanced production detected two hours following exposure.	6-Ketoprostaglandin F1 alpha	41-57	interleukin 1 beta	Homo sapiens	0-8